TNF and cancer: It was demonstrated that the production of proinflammatory TNF-α was significantly lower in atherosclerotic patients and significantly higher in cancer patients in comparison to healthy subjects, whereas the production of anti-inflammatory CCL18 was decreased in both atherosclerosis and cancer patients [40].